Phytochemicals and Nanoparticles in the Modulation of PI3K/Akt/mTOR Kinases and its Implications in the Development and Progression of Gastrointestinal Cancers: A Review of Preclinical and Clinical Evidence

被引:4
作者
Narayanankutty, Arunaksharan [1 ]
Nambiattil, Sreelakshmi [1 ]
Mannarakkal, Sreeshna [1 ]
机构
[1] St Josephs Coll Autonomous, Post Grad & Res Dept Zool, Div Cell & Mol Biol, Calicut, Kerala, India
关键词
H Gastrointestinal cancer; PI3K/Akt signaling; phytochemicals; carcinogenesis; drug resistance; metastasis; colorectal cancer; gastric cancer; hepatocellular carcinoma; HUMAN GASTRIC-CANCER; CELL-CYCLE ARREST; HEPATOCELLULAR-CARCINOMA CELLS; NF-KAPPA-B; MITOCHONDRIAL-DEPENDENT APOPTOSIS; PROMOTES CISPLATIN RESISTANCE; I DOSE-ESCALATION; COLON-CANCER; SIGNALING PATHWAY; COLORECTAL-CANCER;
D O I
10.2174/1574892817666220606104712
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Gastrointestinal cancer are the major form of cancer in developing countries, which comprises gastric cancer (GC), hepatic cancer (HCC), colorectal cancers (CRC), etc.; they account for a large number of cancer-related deaths globally. Gastrointestinal cancers generally have a multifactorial origin, where both genetic and dietary factors play prominent roles. PI3K/Akt signaling is the prime signaling pathway associated with the Phosphoinositide-3 kinase/protein kinase B signaling pathway.Objective: The present review aims to summarize the role of the PI3K/Akt signaling pathway on the different events of gastrointestinal cancers, such as proliferation, survival, metastasis, angiogenesis, drug resistance and stem cell properties.Methods: Literature collection has been done using the appropriate keywords from PubMed/Medline, Scopus, Web of science, or Eurekaselect. The details of individual types of cancers were selected by giving respective keywords.Results: PI3K signaling pathway is important in various gastrointestinal carcinogenesis and progression events; the pathway is involved in proliferation, survival, metastasis, and drug resistance. Several natural phytochemicals and their derivatives have been shown to inhibit PI3K signaling and its downstream regulatory elements, subsequently resulting in anticancer and anti-metastatic activity. Although numerous preclinical evidences are available, conclusive clinical reports are lacking on the anticancer aspects of PI3K inhibitors in gastric cancer.Conclusion: Phytochemicals are promising drug candidates for targeting the PI3K/mTOR pathway in various gastrointestinal cancer treatments. However, there is a need for extensive clinical studies to ascertain the commercial value of anticancer therapeutic compounds against cancers of the stomach, liver, and intestine.
引用
收藏
页码:307 / 324
页数:18
相关论文
共 6 条
  • [1] PI3K/Akt/mTOR Pathway as a Therapeutic Target for Colorectal Cancer: A Review of Preclinical and Clinical Evidence
    Narayanankutty, Arunaksharan
    CURRENT DRUG TARGETS, 2019, 20 (12) : 1217 - 1226
  • [2] Targeting PI3K/Akt/mTOR in AML: Rationale and Clinical Evidence
    Darici, Salihanur
    Alkhaldi, Hazem
    Horne, Gillian
    Jorgensen, Heather G.
    Marmiroli, Sandra
    Huang, Xu
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09) : 1 - 40
  • [3] Review of PI3K/mTOR Inhibitors Entering Clinical Trials to Treat Triple Negative Breast Cancers
    Fouque, Amelie
    Jean, Mickael
    van de Weghe, Pierre
    Legembre, Patrick
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2016, 11 (03) : 283 - 296
  • [4] LncRNA MALAT1 Expression Regulates Breast Cancer Progression via PI3K/AKT/mTOR Pathway Modulation
    Naveed, Mariam
    Malik, Ayesha
    Anjum, Hamza
    Ijaz, Bushra
    BIOCHEMICAL GENETICS, 2024, 62 (05) : 3421 - 3438
  • [5] Clinical implications of the interaction between PD-1/PD-L1 and PI3K/AKT/mTOR pathway in progression and treatment of non-small cell lung cancer
    Quan, Zihan
    Yang, Yang
    Zheng, Hongmei
    Zhan, Yuting
    Luo, Jiadi
    Ning, Yue
    Fan, Songqing
    JOURNAL OF CANCER, 2022, 13 (13): : 3434 - 3443
  • [6] miR-425-5p promoting colorectal carcinoma progression by regulating its target gene PTEN to change activity of the PI3K/AKT/mTOR signaling pathway
    Zhao, Yijiang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2021, 14 (01): : 144 - 153